|
Volumn 67, Issue 2, 2004, Pages 27-30
|
Trimetazidine protects myocardium from reperfusive damage during thrombolytic treatment of acute infarction
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATINE KINASE;
TRIMETAZIDINE;
ARTICLE;
BLOOD CLOT LYSIS;
CONTROLLED STUDY;
CREATINE KINASE BLOOD LEVEL;
DATA ANALYSIS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
ELECTROCARDIOGRAM;
HEART INFARCTION;
HEART MUSCLE;
HEART PROTECTION;
HUMAN;
LIPID PEROXIDATION;
QRS COMPLEX;
REPERFUSION INJURY;
TREATMENT OUTCOME;
ADULT;
AGED;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FEMALE;
FIBRINOLYTIC THERAPY;
MALE;
METABOLISM;
MIDDLE AGED;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
AGED;
FEMALE;
HUMANS;
LIPID PEROXIDATION;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
MYOCARDIAL REPERFUSION INJURY;
MYOCARDIUM;
THROMBOLYTIC THERAPY;
TRIMETAZIDINE;
|
EID: 2542487307
PISSN: 08692092
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (16)
|